EU Approves Dapagliflozin for Kidney Disease, Regardless of Diabetes ...Middle East

The decision rested on results from the DAPA-CKD pivotal trial and followed US FDA approval last April for adults with chronic kidney disease regardless of whether they also have type 2 diabetes. International Approvals

Hence then, the article about eu approves dapagliflozin for kidney disease regardless of diabetes was published today ( Tuesday 10/08/2021 - 09:16 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EU Approves Dapagliflozin for Kidney Disease, Regardless of Diabetes )

Also on site :

• Prof. Schlevogt’s Compass No. 57: Liquidating tomorrow – When states kill possibility, not persons
• The World’s Most Famous Ocean Liner Where Royalty and Rockstars Once Ruled the Atlantic Sailed Her Maiden Voyage 57 Years Ago Today
• The 8 Best Airport Lounges for 2026 According to The Points Guy